BORGIANI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 34.607
EU - Europa 2.903
AS - Asia 1.262
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 12
AF - Africa 5
OC - Oceania 4
Totale 38.810
Nazione #
US - Stati Uniti d'America 34.583
SG - Singapore 666
DE - Germania 483
UA - Ucraina 447
IT - Italia 405
CN - Cina 367
IE - Irlanda 365
FR - Francia 225
PL - Polonia 220
RU - Federazione Russa 208
GB - Regno Unito 174
SE - Svezia 158
FI - Finlandia 115
KR - Corea 90
BE - Belgio 30
KG - Kirghizistan 28
JP - Giappone 22
CZ - Repubblica Ceca 21
IR - Iran 20
NL - Olanda 20
CA - Canada 18
TR - Turchia 14
IN - India 13
VN - Vietnam 12
EU - Europa 11
HK - Hong Kong 8
BR - Brasile 7
UZ - Uzbekistan 7
A2 - ???statistics.table.value.countryCode.A2??? 6
RO - Romania 6
MX - Messico 5
AT - Austria 3
AU - Australia 3
BD - Bangladesh 3
CL - Cile 3
GR - Grecia 3
HU - Ungheria 3
IQ - Iraq 3
MA - Marocco 3
MY - Malesia 3
BG - Bulgaria 2
CH - Svizzera 2
EG - Egitto 2
IS - Islanda 2
LT - Lituania 2
PT - Portogallo 2
AL - Albania 1
BY - Bielorussia 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 38.810
Città #
Woodbridge 9.831
Wilmington 9.461
Houston 8.577
Fairfield 1.197
Ann Arbor 737
Chandler 643
Singapore 594
Ashburn 508
Seattle 430
Cambridge 389
Jacksonville 364
Dublin 337
New York 306
Medford 260
Kraków 215
Rome 175
Dearborn 159
Beijing 134
Santa Clara 123
Lawrence 120
Boardman 110
Menlo Park 94
San Diego 60
Moscow 41
Redwood City 33
Milan 31
Zhengzhou 31
Palo Alto 30
Mülheim 27
Norwalk 26
Helsinki 24
Brussels 23
London 23
Mountain View 23
Munich 23
Hefei 21
Shanghai 20
Los Angeles 19
University Park 17
Seoul 15
Nanjing 12
Olomouc 12
Detroit 11
Hangzhou 11
Kunming 11
Toronto 11
Creede 10
Hanoi 9
Verona 9
Brno 8
Nürnberg 8
Guangzhou 7
Hebei 7
Jinan 7
Kilburn 7
Saint Petersburg 7
San Mateo 7
Center 6
Frankfurt am Main 6
Fuzhou 6
Hong Kong 6
Indiana 6
Quzhou 6
Turhal 6
Waanrode 6
Amsterdam 5
Atlanta 5
Changsha 5
Chiswick 5
Falls Church 5
Hounslow 5
Istanbul 5
Lappeenranta 5
Perugia 5
Phoenix 5
Shenyang 5
Shenzhen 5
Auburn Hills 4
Chengdu 4
Chongqing 4
Islington 4
Livorno 4
Nanchang 4
New Bedfont 4
Novi Velia 4
Nuremberg 4
Québec 4
San Francisco 4
Tappahannock 4
The Dalles 4
Abbadia San Salvatore 3
Anzio 3
Baotou 3
Budapest 3
Castignano 3
Clearwater 3
Corridonia 3
Council Bluffs 3
Delhi 3
Dhaka 3
Totale 35.595
Nome #
ATG16L1 Ala197Thr Is Not Associated With Susceptibility to Crohn's Disease or With Phenotype in an Italian Population 464
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 461
CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population 446
High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase 442
Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians 435
3020insC mutation within the NOD2 gene in Crohn's disease: frequency and association with clinical pattern in an Italian population 435
TCF7L2 gene polymorphisms and type 2 diabetes: Association with diabetic retinopathy and cardiovascular autonomic neuropathy 428
A family study of asymptomatic small bowel Crohn's disease 426
Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes 426
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population 423
Age-related macular degeneration: insights into inflammatory genes 423
Advances in exploring the role of micrornas in inflammatory bowel disease 423
Folic acid and methionine in the prevention of teratogen-induced congenital defects in mice 421
Intrauterine development and MNSs blood groups in repeated spontaneous abortion. 420
A Pharmacogenetics Study in Mozambican Patients Treated with Nevirapine: Full Resequencing of TRAF3IP2 Gene Shows a Novel Association with SJS/TEN Susceptibility 419
Type 2 diabetes and the genetics of signal transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms 418
Direct PCR: a new pharmacogenetic approach for the inexpensive testing of HLA-B*57:01 418
Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's disease 416
Interleukin-23R Arg381Gln Is Associated With Susceptibility to Crohn's Disease But Not With Phenotype in an Italian Population 415
Foetal macrosomia and erythrocyte acid phosphatase (ACP1) polymorphism in diabetic and normal pregnancy. 414
Genetic factors in systemic lupus erythematosus: Contribution to disease phenotype 414
Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study 413
HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons syndrome/toxic epidermal necrolysis susceptibility in a population from Mozambique 412
Crohn's disease, the mycobacterium paratuberculosis and the genetic bond: An unexpected trio 410
A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene 409
Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient 408
Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique 406
Cannabinoid Poisoning by Hemp Seed Oil in a Child 405
Role of genetics in prevention of coronary atherosclerosis 404
Association between ACP(1) and favism: A possible biochemical mechanism 402
TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development 401
Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction 401
Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases 401
Recent advances in exploring the genetic susceptibility to diabetic neuropathy 400
FLG (filaggrin) null mutations and sunlight exposure: Evidence of a correlation 400
Pharmacogenomics of multifactorial diseases: A focus on psoriatic arthritis 399
Comparative analysis between saliva and buccal swabs as source of DNA: Lesson from HLA-B∗57:01 testing 396
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 395
Biomarkers to predict drug efficacy and safety in neurodegenerative diseases 394
Association of the ACP1 genotype with metabolic parameters upon initial diagnosis of type 1 diabetes. 394
A study of three polymorphic sites of the ADA gene in children with type 1 diabetes mellitus 392
Identification of two SNPs in the 5' flanking region of the ACP1 gene and evaluation of disequilibrium among polymorphic sites. 391
Neonatal screening, clinical features and genetic testing for galactosemia [3] 390
Enzyme variability and neonatal jaundice. The role of adenosine deaminase and acid phosphatase 390
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis 387
Ala197Thr is not associated with susceptibility to Crohn’s Disease or with phenotype in an Italian population. 384
EPHX1 Polymorphisms Are Not Associated With Warfarin Response in an Italian Population 383
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease 383
Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. 383
Increased release and activity of matrix metalloproteinase-9 in patients with mandibuloacral dysplasia type A, a rare premature ageing syndrome 382
Diabetic complications and the genetics of signal transduction. A study of retinopathy in NIDDM 382
Phosphotyrosine-protein-phosphatase and diabetic disorders. Further studies on the relationship between low molecular weight acid phosphatase genotype and degree of glycemic control 381
Recent advances in the genetic susceptibility to osteoarthritis 381
Two molecular assays for the rapid and inexpensive detection of GJB2 and GJB6 mutations 381
Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population 380
Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy 379
TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in Inflammatory Bowel Disease 376
Genotyping OLR1 gene: A genomic biomarker for cardiovascular diseases 372
MicroRNA genetic variations: association with type 2 diabetes 372
RH blood groups and diabetic disorders: Is there an effect on glycosylated hemoglobin level? 372
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 371
Correction: A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics 370
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses 367
A study of human growth hormone and insulin gene regions in relation to metabolic control of non-insulin-dependent diabetes mellitus 365
Phosphoglucomutase genetic polymorphism of newborns 363
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 362
Further evidence that polymorphisms of the OLR1 gene are associated with susceptibility to coronary artery disease and myocardial infarction 360
ABCC10 rs2125739 polymorphism and nevirapine-induced hepatotoxicity: lack of association in a population from Mozambique 360
L’impatto sulla salute umana dell’arsenico presente in basse concentrazioni nelle acque. Proposta di uno studio caso controllo Nested nell’area del viterbese 359
Genetic control of serum IgE levels: a study of low molecular weight protein tyrosine phosphatase. 358
Acid phosphatase locus 1 (ACP1): Possible relationship of allelic variation to body size and human population adaptation to thermal stress - A theoretical perspective 356
Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study 355
Assessing individual risk for AMD with genetic counseling, family history, and genetic testing 355
OLR1 gene and coronary artery disease/acute myocardial infarction: Replication in an independently collected sample [1] 352
New insights in atherosclerosis research: LOX-1, leading actor of cardiovascular diseases [Nuovi approfondimenti nella ricerca su l'ateroslerosi: LOX-1, un primo attore nelle malattie cardiovascolari] 351
IL-4 receptor alpha chain genetic polymorphism and total IgE levels in the English population: two-locus haplotypes are more informative than individual SNPs 351
Rh blood groups and diabetic disorders 351
Could MicroRNA polymorphisms influence warfarin dosing? A pharmacogenetics study on mir133 genes 350
Pharmacogenomics: role in medicines approval and clinical use 349
Genetic tests and genomic biomarkers: regulation, qualification and validation 349
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 346
Low molecular weight PTP-IL-4RA interaction in atopy predisposition 341
Foetal macrosomia in diabetic pregnancy. Further data on the association with maternal PGM1 genotype 340
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication 328
Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility 328
Genetics and Treatment Response in Parkinson’s Disease: An Update on Pharmacogenetic Studies 323
Pharmacogenetics of inflammatory bowel disease: A focus on Crohn's disease 315
A common polymorphism in MIR155 gene promoter region is associated with a lower risk to develop type 2 diabetes 303
Genotypes of cytosolic low-molecular-weight protein-tyrosine-phosphatase correlate with age at onset of type 1 diabetes in a sex-specific manner. 296
Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population 275
Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility 271
A multivariate genetic analysis confirms rs5010528 in the human leucocyte antigen-C locus as a significant contributor to Stevens-Johnson syndrome/toxic epidermal necrolysis susceptibility in a Mozambique HIV population treated with nevirapine 264
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 252
Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypes 242
STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects 238
Interaction between microbiome and host genetics in psoriatic arthritis 236
Pharmacogenomics in Parkinson's disease: which perspective for developing a personalized medicine? 232
Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: Significant association of twelve variants 218
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals 190
miRNAs in drug response variability: potential utility as biomarkers for personalized medicine 180
Totale 36.950
Categoria #
all - tutte 78.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.033 0 0 0 0 867 1.097 977 940 843 944 626 739
2020/20216.655 692 760 680 826 777 737 847 731 159 157 220 69
2021/20221.359 75 134 60 83 52 145 67 55 125 122 104 337
2022/20231.664 171 142 47 232 158 383 142 99 137 20 87 46
2023/2024860 85 20 41 26 49 334 34 41 12 8 16 194
2024/20251.319 92 673 310 228 16 0 0 0 0 0 0 0
Totale 39.297